Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 17, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

Psoriasis

Interventions

DRUG

PRX003

OTHER

Placebo

Trial Locations (9)

UPMC Department of Dermatology, Pittsburgh

Altoona Center for Clinical Research, Duncansville

Virginia Clinical Research Inc., Norfolk

Renstar Medical Research, Ocala

University Hospitals Case Medical Center, Cleveland

TCR Medical Corporation, San Diego

Universal Medical and Research Center, LLC, Coral Gables

Dermatology Treatment and Research Center, PA, Dallas

Clinical Trials of Texas, Inc., San Antonio

All Listed Sponsors

lead

Prothena Biosciences Limited

INDUSTRY

NCT02630901 - Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis | Biotech Hunter | Biotech Hunter